Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

A gluten-free diet significantly improves skin and health issues in people with dermatitis herpetiformis, a skin condition linked to celiac disease.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Vitiligo patients often have other health issues, especially thyroid disorders.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Japanese vitiligo patients and their families often have other autoimmune diseases.

The pituitary gland controls seasonal fur color changes in weasels.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Women with thinning hair have thinner hair strands than women without hair loss.

Eating phenylthiocarbamide made all the rats' hair go gray, but some returned to their original color after stopping.

SHBG may be a useful early indicator and treatment target for PCOS.

Alopecia areata patients often have eczema, thyroid issues, vitamin-D deficiency, and anemia.

Zinc supplements may be needed to treat hair loss in hypothyroidism.

Hormones control keratin production in skin and hair.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Hidden sweat gland tumors might cause hair loss.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Hypothyroidism in dogs can cause aggression, which can be treated with thyroid therapy.